1. A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming
   Lorena Incorvaia et al, 2020, Cancers CrossRef
2. Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC)
   María Armesto et al, 2021, Cancers CrossRef
3. Optimization of BCG Therapy Targeting Neutrophil Extracellular Traps, Autophagy, and miRNAs in Bladder Cancer: Implications for Personalized Medicine
   Chenyu Mao et al, 2021, Front. Med. CrossRef
4. Advances in Renal Cell Carcinoma Drug Resistance Models
   Yien Xiang et al, 2022, Front. Oncol. CrossRef
5. Characterization of Cell Surface Glycoproteins Using Enzymatic Treatment and Mass Spectrometry
   Ding Chiao Lin et al, 2024, Anal. Chem. CrossRef